1. |
Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation, 1996, 93(6): 1262-1277.
|
2. |
Pappone C, Oral H, Santinelli V, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation, 2004, 109(22): 2724-2726.
|
3. |
佘飞, 刘书旺, 郭丽君. 左心耳封堵术在心房颤动患者中的应用价值. 中国心血管杂志, 2013, 18(6): 409-411.
|
4. |
赵刚, 程蕾蕾, 裴晓黎, 等. 室壁运动异常患者左室射血分数超声心动图检测方法的选择. 中国临床医学, 2016, 23(3): 299-302.
|
5. |
冯婷婷, 贾淑杰, 赵全明. 高密度脂蛋白胆固醇水平与慢性心力衰竭严重程度的相关性. 心肺血管病杂志, 2018, 37(8): 735-739.
|
6. |
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 2016, 29(4): 277-314.
|
7. |
Toyama K, Rader F, Kar S, et al. Iatrogenic atrial septal defect after percutaneous mitral valve repair with the MitraClip system. AmJ Cardiol, 2018, 121(4): 475-479.
|
8. |
Katz NM, Hannan RL, Hopkins RA, et al. Cardiac operations in patients aged 70 years and over: mortality, length of stay, and hospital charge. Ann Thorac Surg, 1995, 60(1): 96-100.
|
9. |
Agrifoglio M, Trabattoni D, Rossi F, et al. Percutaneous closure of iatrogenic atrial septal defect due to implantation of a left-left "Tandem Heart" ventricle assistance device in a postcardiotomy cardiac failure: six-year follow-up. J Cardiovasc Surg (Torino), 2012, 53(2): 270-272.
|
10. |
Losi M, Strisciuglio T, Stabile E, et al. Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of PaO2/FiO2 ratio in guiding post-procedural iASD closure. Int J Cardiol, 2015, 197: 85-86.
|
11. |
Aznaouridis K, Hobson N, Rigg C, et al. Emergency percutaneous closure of an iatrogenic atrial septal defect causing right-to-left shunt and severe refractory hypoxemia after pulmonary vein isolation. JACC Cardiovasc Interv, 2015, 8(11): e179-e181.
|
12. |
Rillig A, Meyerfeldt U, Birkemeyer R, et al. Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol, 2008, 22(3): 177-181.
|
13. |
Hammerstingl C, Lickfett L, Jeong KM, et al. Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?. Am Heart J, 2006, 152(2): 362.e1-362.e5.
|
14. |
Rillig A, Meyerfeldt U, Kunze M, et al. Persistent iatrogenic atrial septal defect after a single-puncture, double-transseptal approach for pulmonary vein isolation using a remote robotic navigation system: results from a prospective study. Europace, 2010, 12(3): 331-336.
|
15. |
Davies A, Gunaruwan P, Collins N, et al. Persistent iatrogenic atrial septal defects after pulmonary vein isolation: long-term follow-up with contrast transesophageal echocardiography. J Interv Card Electrophysiol, 2017, 48(1): 99-103.
|
16. |
吴书林, 廖洪涛, 费洪文, 等. 阵发性心房颤动射频消融术后左房大小和机械功能变化. 中华心血管病杂志, 2007, 35(2): 127-131.
|
17. |
夏曦. 房间隔缺损合并肺动脉高压患儿导管封堵术后左房结构及功能的变化. 临床心血管病杂志, 2015, 31(1): 54-56.
|
18. |
李靖, 刘延玲, 何青, 等. 正常人群年龄进程中心脏结构和功能的变化特点. 中华心血管病杂志, 2010, 38(1): 52-56.
|
19. |
武思雯, 张荣峰, 尹晓盟, 等. 房颤患者术后医源性房间隔缺损发生情况及影响因素分析. 中国医药导报, 2020, 17(11): 44-47.
|
20. |
Singh SM, Douglas PS, Reddy VY. The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath. Circ Arrhythm Electrophysiol, 2011, 4(2): 166-171.
|
21. |
Noheria A, Roshan J, Kapa S, et al. Migraine headaches following catheter ablation for atrial fibrillation. J Interv Card Electrophysiol, 2011, 30(3): 227-232.
|